Clinical Study
Tetrahydrocannabinol (Delta 9-THC) Treatment in Chronic Central Neuropathic Pain and Fibromyalgia Patients: Results of a Multicenter Survey
Table 3
Estimated pain intensity (VRS) and maximum/minimum pain (NRS) recorded in the subgroups of “inflammatory central neuropathy”—“central neuropathic pain due to trauma”—“fibromyalgia” prior to and during/after delta 9-THC therapy. No significant differences between the groups could be analysed. In each group, delta 9-THC medication caused a noticeable amelioration of pain.
|